Iron chelator differentially activates macrophage inflammatory protein-3α/CCL20 in immortalized and malignant human oral keratinocytes

Archives of Oral Biology

Volumn 53, Issue 9, 2008, Pages 801-809

  Lee, Sun Kyung ^a   Lee, Jun ^a   Min, Seung Ki ^a   Won, Dal Ho ^a   Lee, You Mee ^a   Lim, Hyun Dae ^a   Lee, Wan ^a   Pae, Hyun Ock ^a   Chung, Hun Taeg ^a   Jun, Chang Duk ^b   Lee, Suk Keun ^c   Kim, Eun Cheol ^a  

^a Wonkwang University   (South Korea)

^b Gwangju Institute of Science and Technology (GIST)   (South Korea)

^c Gangneung Wonju National University   (South Korea)

Author keywords

CCL20; Immortalized keratinocytes; Iron chelator; MAP kinase; NF B; Oral cancer

Indexed keywords

CCL20 PROTEIN, HUMAN; DEFEROXAMINE; FERRIC CITRATE; FERRIC ION; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON CHELATING AGENT; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA;

ARTICLE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; KERATINOCYTE; MALE; METABOLISM; MOUTH TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE;

CARCINOMA, SQUAMOUS CELL; CHEMOKINE CCL20; DEFEROXAMINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRIC COMPOUNDS; GENE EXPRESSION; HUMANS; IRON CHELATING AGENTS; KERATINOCYTES; MALE; MOUTH NEOPLASMS; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 47249110726     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2008.01.015     Document Type: Article

References (44)

1. Marcus B., Arenberg D., Lee J., Kleer C., Chepeha D.B., Schmalbach C.E., et al. Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer 15 (2004) 2779-2787
2. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127
3. Yoshie O., Imai T., and Nomiyama H. Chemokines in immunity. Adv Immunol 78 (2001) 57-110
4. Whiteside T.L., Letessier E., Hirabayashi H., Vitolo D., Bryant J., Barmes L., et al. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck. Cancer Res 53 (1993) 5654-5662
5. Barrera J.L., Verastegui E., Meneses A., Zinser J., de la Garza J., and Hadden J.W. Combination immunotherapy of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 126 (2000) 345-351
6. Schutyser E., Struyf S., Menten P., Lenaerts J.P., Conings R., Put W., et al. Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 from normal and transformed cells. J Immunol 165 (2000) 4470-4477
7. Hieshima K., Imai T., Opdenakker G., Van Damme J., Kusuda J., Tei H., et al. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem 272 (1997) 5846-5853
8. Tanaka Y., Imai T., Baba M., Ishikawa I., Uehira M., Nomiyama H., et al. Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur J Immunol 29 (1999) 633-642
9. Rossi D.L., Vicari A.P., Franz-Bacon K., McClanahan T.K., and Zlotnik A. Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3 and MIP-3. J Immunol 158 (1997) 1033-1036
10. Izadpanah A., Dwinell M.B., Ecjmann L., Varki N.M., and Kagnoff M.F. Regulated MIP3α/CCL20 production in human interstinal epithelium: mechanism for modulating mucosal immunity. Am Physiol Gastrointest Liver Physiol 280 (2001) G710-G719
11. Kleeff J., Kusama T., Rossi D.L., Ishiwata T., Maruyama H., Friess H., et al. Detection and localization of MIP-3α/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic carcinoma. Int J Cancer 81 (1999) 650-657
12. Fushimi T., Kojima A., Moore M.A.S., and Crystal R.G. Microphage inflammatory protein 3α transgene attracts dendritic cells to established murine tumors and suppress tumor growth. J Clin Invest 105 (2000) 1383-1393
13. Abiko Y., Nishimura M., Kusano K.M., Nakashima K., Okkumura K., Arakawa T., et al. Expression of MIP-3α/CCL20, a macrophage inflammatory protein in oral squamous cell carcinoma. Arch Oral Biol 48 (2003) 171-175
14. Crichton R.R., and Ward R.J. Iron metabolism-new perspectives in view. Biochemistry 31 (1992) 11255-11264
15. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 20 (1996) 553-566
16. Weinberg E.D. Iron, asbestos, and carcinogenicity. Lancet 1 (1989) 1399-1400
17. Lee S.K., Lee J.J., Lee H.J., Lee J., Jeon B.H., Jun C.D., et al. Iron chelator-induced growth arrest and cytochrome c-dependent apoptosis in immortalized and malignant oral keratinocytes. J Oral Pathol Med 35 (2006) 218-226
18. Lee S.K., Jang H.J., Lee H.J., Lee J., Jeon B.H., Jun C.D., et al. p38 and ERK MAP kinase mediates iron chelator induced-apoptosis and -suppressed differentiation in immortalized and malignant human oral keratinocytes. Life Sci 79 (2006) 1419-1427
19. Cardinali M.H., Pietraszkiewicz J.F., and Robbins K.C. Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies. Int J Cancer 61 (1995) 98-103
20. Sierro F., Dubois B., Coste A., Kaiserlian D., Kraehenbuhl J.P., and Sirard J.C. Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc Natl Acad Sci 98 (2001) 13722-13727
21. Scapini P., Crepaldi L., Pinardi C., Calzetti F., and Cassatella M.A. CCL20/macrophage inflammatory protein-3α production in LPS-stimulated neutrophils is enhanced by the chemoattractant formyl-methionyl-leucyl-phenylalanine and IFN-γ through independent mechanisms. Eur J Immunol 32 (2002) 3515-3524
22. Choi E.Y., Kim E.C., Oh H.M., Kim S., Lee H.J., Yoon K.H., et al. Iron chelator triggers inflammatory signals in human intestinal epithelial cells: involvement of p38 and extracellular signal-regulated kinase signaling pathways. J Immunol 172 (2004) 7069-7077
23. Nakagawa H., Matsumuiya T., Sakaki H., Imaizumi T., Kubota K., Kusumi A., et al. Expression of vascular endothelial growth factor by photodynamic therapy with mono-l-aspartyl chlorin e6 (Npe6) in oral squamous cell carcinoma. Oral Oncol 43 (2007) 544-550
24. Shin K.H., Min B.M., Cherrick H.M., and Park N.H. Combined effects of human papillomavirus-18 and N-methyl-N′-nitro-N-nitrosoguanidine on the transformation of normal human oral keratinocytes. Mol Carcinogen 9 (1994) 76-86
25. Park N.H., Gujuluva C.N., Baek J.H., Cherrick H.M., Shin K.H., and Min B.M. Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model. Oncogene 10 (1995) 2145-2153
26. Seligman P.A., Kovar J., and Gelfand E.W. Lymphocyte proliferation is controlled by both iron availability and regulation of iron uptake pathways. Pathobiology 60 (1992) 19-26
27. Mainou-Fowler T., and Brock J.H. Effect of iron deficiency on the response of mouse lymphocytes to concanavalin A: the importance of transferrin-bound iron. Immunology 54 (1985) 325-332
28. Wesselborg S., Bauer M.K., Vogt M., Schmitz M.L., and Schulze-Osthoff K. Activation of transcription factor NF-κB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways. J Biol Chem 272 (1997) 12422-12429
29. O'Brien-Ladner A.R., Blumer B.M., and Wesselius L.J. Differential regulation of human alveolar macrophage-derived interleukin-1β and tumor necrosis factor-α by iron. J Lab Clin Med 132 (1998) 497-506
30. Nakayama T., Fujisawa R., Yamada H., Horikawa T., Kawasaki H., Hieshima K., et al. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3α/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int Immunol 13 (2000) 95-103
31. Schutyser E., Struyf S., Menten P., Lenaerts J.P., Conings R., Put W., et al. Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3α from normal and transformed cells. J Immunol 165 (2000) 4470-4477
32. Luster A.D. Chemokines, chemotactic cytokines that mediate inflammation. N Engl J Med 338 (1998) 436-445
33. Wang J.M., Deng X., Gong W., and Su S. Chemokines and their role in tumor growth and metastasis. J Immunol Methods 220 (1998) 1-17
34. Karin M., Liu Z., and Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 9 (1997) 240-246
35. Cassatella M.A. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 16 (1995) 21-26
36. Fujiie S., Hieshima K., Izawa D., Nakayama T., Fujisawa R., Ohyanagi H., et al. Proinflammatory cytokines induce liver and activation-regulated chemokine/MIP-3alpha/CCL20 in mucosal epithelial cells through NF-kB. Int Immunol 13 (2001) 1255-1263
37. Vlahopoulos S., Boldogh I., Casola A., and Brasier A.R. Nuclear factor κB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 94 (1999) 1878-1889
38. Millar A.D., Rampton D.S., and Blake D.R. Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis. Aliment Pharmacol Ther 14 (2000) 1163-1168
39. Haas M., Page S., Page M., Neumann F.J., Marx N., Adam M., et al. Effect of proteasome inhibitors on monocytic IkappaB-alpha and -beta depletion, NF-kappaB activation, and cytokine production. J Leukoc Biol 63 (1998) 395-404
40. Kleinert H., Pautz A., Linker K., and Schwarz P.M. Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 500 (2004) 255-266
41. Schreck R., Meier B., Mannel D.N., Droge W., and Baeuerle P.A. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 175 (1992) 1181-1194
42. Brand S., Olszak T., Beigel F., Diebold J., Otte J.M., Eichhorst S.T., et al. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. J Cell Biochem 97 (2006) 709-723
43. Kleeff J., Kusama T., Rossi D.L., Ishiwata T., Maruyama H., Friess H., et al. Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer 81 (1999) 650-657
44. Fujii H., Itoh Y., Yamaguchi K., Yamauchi N., Harano Y., Nakajima T., et al. Chemokine CCL20 enhances the growth of HuH7 cells via phosphorylation of p44/42 MAPK in vitro. Biochem Biophys Res Commun 322 (2004) 1052-1058